Trial intelligence / Profile preview

Pralatrexate in Relapsed or Refractory Peripheral T-cell Lymphoma (China, Phase 3)

CTR20150402Phase 3Active

Sponsor

Allos Therapeutics

Start

Jun 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1